drugset / Trial / NCT00648362
Fasting Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mg
RandomizedCrossoverOpen-labelOther
Summary
The objective of this study was to investigate the bioequivalence of Mylan's glimepiride 1 mg tablets to Aventis Amaryl® 1 mg tablets following a single, oral 1 mg (1 x 1 mg) dose administered under fasting conditions.
Timeline
- Start
- 2004-11
- Primary completion
- 2004-11
- Completion
- 2004-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glimepiride | Small molecule | 1 mg | Oral |
Indications
No indication recorded.